This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

BIOFIRE® Filmarray® Gastrointestinal (GI) Panel

Last updated

Summary

Product
BIOFIRE® Filmarray® Gastrointestinal (GI) Panel
Issue
Medical devices - Sterility
What to do

Contact the importer, Biomérieux Canada Inc. 

Audience
Healthcare

Affected products

Affected products Lot or serial number Model or catalog number
BIOFIRE® Filmarray® Gastrointestinal (GI) Panel 782425 712258 743930 742049 769240 RFIT-ASY-0116 RFIT-ASY-0104

Issue

An increased number of customer complaints associated with Vibrio/Vibrio Cholerae false positive detections by the BIOFIRE Filmarray Gastrointestinal (GI) Panel have been observed when using Remel Cary-Blair transport medium. The BIOFIRE GI panel and the Cary-Blair transport medium are performing as intended.

Per INV-19261, the root cause of the false positive Vibrio/Vibrio Cholerae results detected by the BIOFIRE GI panel is the presence of non-viable organism in the Remel Cary-Blair transport medium.

Recall Start Date: July 4, 2024

Additional information

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Microbiology
Companies

Biofire Diagnostics, Llc.

515 Colorow Dr., Salt Lake City, Utah, United States, 84108

Published by
Health Canada
Audience
Healthcare
Recall class
Type II
Identification number
RA-75827

Get notified

Receive emails about new and updated recall and safety alerts.

Subscribe